Aspirin Use May Decrease Ventilation, ICU Admission and Death in COVID-19 Patients

GW researchers found that aspirin may have lung-protective effects and reduce in-hospital mortality in hospitalized COVID-19 patients.
March 25, 2021

George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients, according to a new study.

“As we learned about the connection between blood clots and COVID-19, we knew that aspirin—used to prevent stroke and heart attack—could be important for COVID-19 patients,” said Jonathan Chow, assistant professor of anesthesiology and critical care medicine and director of the Critical Care Anesthesiology Fellowship at the GW School of Medicine and Health Sciences. “Our research found an association between low dose aspirin and decreased severity of COVID-19 and death...”

Read the full article on GW Today

Latest News

June 20, 2022
Drs. Jacobs and Manfredi published their second installment of the silver linings of Covid in this month's Academic Emergency Medicine
June 20, 2022
Dr. David Yamane worked on a team showing early aspirin use was associated with lower 28-day mortality for Covid patients
June 20, 2022
SGEM critical appraisal of the GRACE2 document-- an interview with the lead author.